Immune Checkpoint Inhibitor Induced Diabetes Mellitus Treated with Insulin and Metformin: Evolution of Diabetes Management in the Era of Immunotherapy

Immune Checkpoint Inhibitor Induced Diabetes Mellitus Treated with Insulin and Metformin: Evolution of Diabetes Management in the Era of Immunotherapy

Immune checkpoint inhibitors (ICPIs) are a breakthrough therapy in oncology and have been approved by the Food and Drug Administration for the treatment of several malignancies. ICPIs have been reported to cause immune-mediated damage of islet cells leading to ICPI-induced type 1 diabetes mellitus (...

Full description

Saved in:
Bibliographic Details
Main Authors: Taha Alrifai, Faisal Shaukat Ali, Sameer Saleem, Diana Carolina Miranda Ruiz, Dana Rifai, Sundas Younas, Faisal Qureshi
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Case Reports in Oncological Medicine
Online Access:http://dx.doi.org/10.1155/2019/8781347
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items